A detailed history of Morgan Stanley transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Morgan Stanley holds 3,626 shares of SRTS stock, worth $19,326. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,626
Previous 3,000 20.87%
Holding current value
$19,326
Previous $7,000 85.71%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.49 - $4.91 $1,558 - $3,073
626 Added 20.87%
3,626 $13,000
Q4 2023

Feb 13, 2024

SELL
$1.87 - $2.71 $7,839 - $11,360
-4,192 Reduced 58.29%
3,000 $7,000
Q3 2023

Nov 15, 2023

SELL
$2.62 - $3.91 $7,105 - $10,603
-2,712 Reduced 27.38%
7,192 $19,000
Q2 2023

Aug 14, 2023

BUY
$2.62 - $5.28 $14,865 - $29,958
5,674 Added 134.14%
9,904 $31,000
Q1 2023

May 15, 2023

BUY
$4.9 - $9.49 $6,487 - $12,564
1,324 Added 45.56%
4,230 $22,000
Q4 2022

Feb 14, 2023

SELL
$5.91 - $7.84 $1.96 Million - $2.61 Million
-332,363 Reduced 99.13%
2,906 $21,000
Q3 2022

Nov 14, 2022

BUY
$7.64 - $14.97 $819,856 - $1.61 Million
107,311 Added 47.07%
335,269 $4.2 Million
Q2 2022

Oct 27, 2022

BUY
$7.06 - $11.37 $1.6 Million - $2.58 Million
226,567 Added 16288.07%
227,958 $1.75 Million
Q2 2022

Aug 15, 2022

BUY
$7.06 - $11.37 $1.6 Million - $2.58 Million
226,567 Added 16288.07%
227,958 $1.75 Million
Q1 2022

Oct 27, 2022

SELL
$6.83 - $11.84 $1.55 Million - $2.68 Million
-226,567 Reduced 99.39%
1,391 $14,000
Q1 2022

May 13, 2022

BUY
$6.83 - $11.84 $9,452 - $16,386
1,384 Added 19771.43%
1,391 $14,000
Q4 2021

Feb 14, 2022

SELL
$3.59 - $8.34 $36,574 - $84,967
-10,188 Reduced 99.93%
7 $0
Q3 2021

Nov 15, 2021

BUY
$3.22 - $4.09 $32,827 - $41,697
10,195 New
10,195 $37,000

Others Institutions Holding SRTS

About Sensus Healthcare, Inc.


  • Ticker SRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,556,000
  • Market Cap $88.2M
  • Description
  • Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...
More about SRTS
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.